跳至主要内容
临床试验/ISRCTN32484878
ISRCTN32484878
已完成
未知

Combination Anti-Rheumatic Drugs in Early Rheumatoid Arthritis

Medical Research Council (MRC) (UK)0 个研究点目标入组 468 人2000年10月25日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Orthopaedics, rheumatology
发起方
Medical Research Council (MRC) (UK)
入组人数
468
状态
已完成
最后更新
9年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2000年10月25日
结束日期
待定
最后更新
9年前
研究类型
Interventional
性别
All

研究者

发起方
Medical Research Council (MRC) (UK)

入排标准

入选标准

  • 1\. RA by the 1987 criteria of the American College of Rheumatology
  • 2\. Disease duration of less than 24 months
  • 3\. The clinical need for treatment with a slow\-acting anti\-rheumatic drug (SAARD) as shown by evidence of active RA
  • 4\. Patients must be willing and able to give informed consent
  • 5\. Age greater than 18

排除标准

  • 1\. Other forms of inflammatory arthritis (e.g. psoriatic arthritis, systemic lupus erythematosus)
  • 2\. Current oral steroids for RA or other conditions (e.g. asthma)
  • 3\. Contra\-indications to methotrexate
  • 4\. Other serious medical disorders (e.g. hepatic failure, cardiac failure, current malignant disease)
  • 5\. Females of child bearing potential who are not taking adequate contraceptive protection
  • 6\. Contra\-indications to cyclosporin therapy
  • 7\. Neutrophil count less than 1\.5 x 10^12 per decilitre or platelet count less than 100 x 10^12 per decilitre
  • 8\. Abnormal liver function test (gamma glutamyl transferase \[gGT] greater than 3 x or aspartate aminotransferase \[AST]/alanine aminotransferase \[ALT] greater than 2 x upper limit of normal)

结局指标

主要结局

未指定

相似试验